Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,165 CAD | -.--% | -17,50% | +65,00% |
Vakgebied
Aantal werknemers: 2
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 01-07-19 |
Soo-Whan Kim
DFI | Director of Finance/CFO | - | 07-01-23 |
Andrew Hegle
BRD | Director/Board Member | 46 | 01-01-20 |
Joseph Cullen
IRC | Investor Relations Contact | 41 | 01-05-19 |
Kelly Pladson
SEC | Corporate Secretary | 42 | - |
Jonna Birgans
PRN | Corporate Officer/Principal | - | 04-02-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 01-07-19 |
Andrew Hegle
BRD | Director/Board Member | 46 | 01-01-20 |
Director/Board Member | 53 | 05-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 858 934 | 8 668 934 ( 97,86 %) | 0 | 97,86 % |
Bedrijfsgegevens
Entheon Biomedical Corp.
999 West Broadway Suite 720
V5Z 1K5, Vancouver
+
http://www.entheonbiomedical.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+65,00% | 1,06 mln. | |
+0,67% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,63 mld. | |
-21,66% | 18,2 mld. | |
+29,96% | 12,01 mld. | |
-1,57% | 11,76 mld. | |
+16,03% | 10,4 mld. | |
-4,80% | 9,94 mld. |
- Beurs
- Aandelen
- Koers ENBI
- Onderneming Entheon Biomedical Corp.